• EF Hutton Initiates Coverage of UroGen Pharma (LSE:0XOD) with Buy Recommendation

    Источник: NASDAQ Stocks / 15 окт 2024 03:15:24   America/Chicago

    Fintel reports that on October 14, 2024, EF Hutton initiated coverage of UroGen Pharma (LSE:0XOD) with a Buy recommendation. https://www.nasdaq.com/articles/ef-hutton-initiates-coverage-urogen-pharma-lse-0xod-buy-recommendation
Опубликовать